{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:14:44Z","timestamp":1791234884222,"version":"4.1.0"},"reference-count":38,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2010,5,14]],"date-time":"2010-05-14T00:00:00Z","timestamp":1273795200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[2010,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background:\u2002<\/jats:bold>Pulmonary hypertension (PHT) is reported to be associated with measures of renal function in patients with sickle cell disease (SCD). The purpose of this exploratory study was to determine the relationship between albuminuria and both clinical and laboratory variables in SCD.<\/jats:p><jats:p><jats:bold>Design and methods:\u2002<\/jats:bold>This cross\u2010sectional study was performed using a cohort of adult patients with SCD and control subjects without SCD. Spot urine for microalbumin\/creatinine ratio, measures of hemolysis, inflammation and other laboratory studies were obtained. Pulmonary artery systolic pressure was determined by Doppler echocardiography, and the diagnosis of PHT was defined using age\u2010, sex\u2010 and body mass index\u2010adjusted reference ranges.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold>Seventy\u2010three patients with SCD and 21 healthy, race\u2010matched control subjects were evaluated. In patients with SCD, normoalbuminuria was observed in 34 patients (46.6%), microalbuminuria in 24 patients (32.9%) and macroalbuminuria in 15 patients (20.5%). There was a significant correlation between urine albumin excretion and age. In patients with HbSS and S\u03b2<jats:sup>0<\/jats:sup>thalassemia, the levels of sFLT\u20101, soluble VCAM and NT pro\u2010BNP were significantly higher in those with macroalbuminuria, compared to patients with microalbuminuria and normoalbuminura, but no significant differences were observed in the levels of laboratory measures of hemolysis. Urine albumin excretion was associated with PHT and a history of stroke.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold>Our study confirms the high prevalence of albuminuria in SCD. The association of urine albumin excretion with sFLT\u20101 suggests that this vascular endothelial growth factor receptor family member may contribute to the development of albuminuria in SCD. By inducing endothelial activation and endothelial dysfunction, sFLT\u20101 appears to be a link between glomerulopathy and PHT in SCD.<\/jats:p>","DOI":"10.1111\/j.1600-0609.2010.01471.x","type":"journal-article","created":{"date-parts":[[2010,5,14]],"date-time":"2010-05-14T17:04:38Z","timestamp":1273856678000},"page":"257-263","source":"Crossref","is-referenced-by-count":59,"title":["Urinary albumin excretion is associated with pulmonary hypertension in sickle cell disease: potential role of soluble fms\u2010like tyrosine kinase\u20101"],"prefix":"10.1111","volume":"85","author":[{"given":"Kenneth I.","family":"Ataga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia E.","family":"Brittain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan K.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Hulkower","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dell","family":"Strayhorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soheir","family":"Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupa","family":"Redding\u2010Lallinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Nachman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene P.","family":"Orringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,8,12]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa035477"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06110.x"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-03-0948"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21058"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.221292098"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1202-799"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11763"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-12-130567"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007956"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-04-217950"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-04-218040"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2002010084"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-200208000-00013"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0b013e3180335081"},{"issue":"2","key":"e_1_2_7_16_2","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification","volume":"39","author":"National Kidney Foundation","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/hc4801.100076"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199406093302303"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20645"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1159\/000178143"},{"key":"e_1_2_7_21_2","doi-asserted-by":"crossref","unstructured":"AtagaKI BrittainJE DesaiP DelaneyJ JonesSK StrayhornD Redding\u2010LallingerR OrringerEP.Association of soluble fms\u2010like tyrosine kinase (sFLT\u20101) with pulmonary hypertension and hemolysis in sickle cell disease. Annual National Sickle Cell Disease Scientific Meeting Hollywood Florida February 2010.","DOI":"10.1111\/j.1365-2141.2010.08410.x"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2524"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2005.11.017"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021942"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030528"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(99)00565-7"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00067.x"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.47.1122"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2006.07.001"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.7.701"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.162.12.1401"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V132504"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.3.310"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.36.3.355"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.08.051"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-115-8-614"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(98)00056-4"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20296"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.2174\/157339908783502361"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.2010.01471.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.2010.01471.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T20:02:49Z","timestamp":1711483369000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.2010.01471.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,12]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["10.1111\/j.1600-0609.2010.01471.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.2010.01471.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,12]]}}}